ArticleFrontiers in oncology2023

Sulfatinib, a novel multi-targeted tyrosine kinase inhibitor of FGFR1, CSF1R, and VEGFR1-3, suppresses osteosarcoma proliferation and invasion

Song Liao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.